Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

James Caruso

Tracked across 1 events · 6 articles · First seen Jul 30, 2026 · Last active Aug 13, 2026

Sentiment
30
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 30
Business
Cellectar Biosciences, a late-stage clinical biopharmaceutical company, announced its second quarter 2026 financial results and provided a corporate update on August 13, 2026. The company reported cash and cash equivalents of $34.0 million as of…
Impact: As CEO, James Caruso provided the corporate update and expressed confidence in the company's strategy and near-term catalysts.
Jul 30, 2026 · 6 articles
ERGEN INTELLIGENCE
Track James Caruso live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.